Comparative effectiveness

Current Opinion in Ophthalmology

Volumn 19, Issue 3, 2008, Pages 175-176

  Brown, Gary ^a  

^a WILLS EYE HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; BEVACIZUMAB; RANIBIZUMAB;

EDITORIAL; HEALTH CARE; HEALTH CARE COST; MEDICARE; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; RETINA MACULA AGE RELATED DEGENERATION; SUBRETINAL NEOVASCULARIZATION; VISION; VITREORETINOPATHY;

AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; HUMANS; MACULAR DEGENERATION; RETINAL NEOVASCULARIZATION; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 42149186986     PISSN: 10408738     EISSN: None     Source Type: Journal    
DOI: 10.1097/ICU.0b013e3282fb7c56     Document Type: Editorial

References (11)

1. Rosenfeld PJ, Brown DM, Heier JS, et al., for the MARINA Study Group. Ranibizumab for neovascular age-related macular degeneration. N Eng J Med 2006; 355:1419-1431.
2. Brown DM, Kaiser PK, Michels M, et al., ANCHOR Study Group. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med 2006; 355:1432-1444.
3. Stone EM. A very effective treatment for neovascular macular degeneration. N Eng J Med 2006; 355:1492-1494.
4. Shah AR, Del Priore LV. Progressive visual loss in subfoveal exudation in age-related macular degeneration: a meta-analysis using Lineweaver-Burke plots. Am J Ophthalmol 2007; 143:83-89.
5. Center for Preventive Ophthalmology and Biostatistics. Comparison of age-related macular degeneration treatments Trials (CATT). http://www.med.upenn. edu/cpob/studies/CATT.shtml. [Accessed 30 January 2008]
6. Ko GJ, Brown MM, Brown GC. The macroeconomics of vitreoretinal diseases. Curr Opin Ophthalmol 2005; 16:184-190.
7. Brown MM, Brown GC, Sharma S. Evidence-based to value-based medicine. Chicago: AMA Press; 2005.
8. Busbee B, Brown MM, Brown GC, Sharma S. Incremental cost-effectiveness of initial cataract surgery. Ophthalmology 2002; 109:606-612.
9. Busbee B, Brown MM, Brown GC, Sharma S. A cost-utility analysis of cataract surgery in the second eye. Ophthalmology 2003; 110:2310-2317.
10. Brown GC, Brown MM, Brown H, Peet JS. A value-based medicine analysis of ranibizumab (MARINA Study) for the treatment of subfoveal neovascular macular degeneration. Ophthalmology (in press).
11. Actuarial Department, Centers for Medicare and Medicaid Services. National healthcare expenditure projections: 2003-2013. http://www.cms.hhs.gov/ NationalHealthExpendData/downloads/proj2006.pdf. [Accessed 31 January 2008]